🎯 Drug Targets

Browse 4 drug targets with druggability analysis, composite scores, and clinical context

4
Targets
0
High Druggability
0.65
Avg Score
15
Target Classes
Druggability Distribution
High: 0Medium: 1Low: 3Unknown: 0
Avg druggability score: 0.391
Clinical Pipeline
Approved: 0Phase III: 3Phase II: 0Phase I: 1Preclinical: 0
Total compounds: 8 · Approved: 0
Filtered by: class=chaperone — 4 results
HSP90AA1 Heat Shock Protein 90 Alpha Family Class A Member Phase 3
Chaperone Low Druggability
Score
0.70
Drug.
0.45
Safety
0.50
Drugs
2
Hyps
2
Papers
14
Small molecule inhibitor binding to ATP-binding pocket of chaperone
HSPA1A Heat Shock Protein Family A Member 1A Phase 3
Chaperone Medium Druggability
Score
0.64
Drug.
0.46
Safety
0.60
Drugs
3
Hyps
3
Papers
46
Small molecule activators or allosteric modulators of chaperone function
NPM1 Nucleophosmin Phase 3
Chaperone Low Druggability
Score
0.63
Drug.
0.30
Safety
0.30
Drugs
1
Hyps
1
Papers
30
Small molecule modulators of nucleolar function and protein interactions
DNAJB1 DnaJ heat shock protein family (Hsp40) member B1 Phase 1
Chaperone Low Druggability
Score
0.60
Drug.
0.35
Safety
0.40
Drugs
2
Hyps
3
Papers
14
Allosteric modulation of protein-protein interactions with Hsp70